Cargando…
Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model
Decrease of GABAergic transmission has been proposed to improve memory functions. Indeed, inverse agonists selective for α5 GABA-A-benzodiazepine receptors (α5IA) have promnesiant activity. Interestingly, we have recently shown that α5IA can rescue cognitive deficits in Ts65Dn mice, a Down syndrome...
Autores principales: | Braudeau, J., Dauphinot, L., Duchon, A., Loistron, A., Dodd, R. H., Hérault, Y., Delatour, B., Potier, M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199058/ https://www.ncbi.nlm.nih.gov/pubmed/22028705 http://dx.doi.org/10.1155/2011/153218 |
Ejemplares similares
-
Specific targeting of the GABA-A receptor α5 subtype by a selective
inverse agonist restores cognitive deficits in Down syndrome
mice
por: Braudeau, J, et al.
Publicado: (2011) -
Long‐lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5‐selective GABA(A) inverse agonist
por: Duchon, Arnaud, et al.
Publicado: (2020) -
Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
por: Laffaire, Julien, et al.
Publicado: (2009) -
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
por: Duchon, Arnaud, et al.
Publicado: (2016) -
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models
por: Souchet, Benoit, et al.
Publicado: (2015)